Literature DB >> 23071134

Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing.

Lisa A Lewis1, William M Shafer, Tathagat Dutta Ray, Sanjay Ram, Peter A Rice.   

Abstract

Loss of phosphoethanolamine (PEA) from the lipid A of gonococcal strain FA19 results in increased sensitivity to killing by the classical pathway of complement. Here we demonstrate that loss of PEA from lipid A diminishes binding of the complement regulatory protein C4b binding protein (C4BP) to the FA19 porin B (PorB), providing a molecular basis to explain the susceptibility of an lptA null strain of FA19 to killing by normal human serum (NHS). Loss of PEA from lipid A in three additional gonococcal strains that expressed diverse PorB molecules also resulted in decreased C4BP binding, increased deposition of C4b, and increased susceptibility to killing by NHS. Complementation of lptA null strains with lptA restored C4BP binding, decreased C4b deposition, and increased resistance to killing by NHS. These effects of lipid A PEA on C4BP binding to gonococcal PorB and serum resistance were simulated when gonococcal PorB was expressed in a meningococcal background. Loss of PEA from lipid A also affected binding of the alternative pathway regulator factor H (fH) to PorB of some strains. For instance, PorB molecules of lptA null mutants of strains 252 and 1291 bound less fH than those of their parent strains when lipooligosaccharide (LOS) was sialylated, whereas PorB molecules of lptA null mutants of strains FA1090 and 273 retained the ability to bind fH when LOS was sialylated. These data indicate that replacement of lipid A with PEA alters binding of C4BP and fH to PorB and contributes to the ability of gonococci to resist complement-mediated killing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23071134      PMCID: PMC3536161          DOI: 10.1128/IAI.00751-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways.

Authors:  Mingfeng Liu; Constance M John; Gary A Jarvis
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 2.  Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies.

Authors:  Kimberly A Workowski; Stuart M Berman; John M Douglas
Journal:  Ann Intern Med       Date:  2008-04-15       Impact factor: 25.391

3.  High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Authors:  Magnus Unemo; Daniel Golparian; Robert Nicholas; Makoto Ohnishi; Anne Gallay; Patrice Sednaoui
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

4.  Molecular characterization of hpuAB, the haemoglobin-haptoglobin-utilization operon of Neisseria meningitidis.

Authors:  L A Lewis; E Gray; Y P Wang; B A Roe; D W Dyer
Journal:  Mol Microbiol       Date:  1997-02       Impact factor: 3.501

5.  Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.

Authors:  C A Nairn; J A Cole; P V Patel; N J Parsons; J E Fox; H Smith
Journal:  J Gen Microbiol       Date:  1988-12

6.  Hepatitis E among U.S. travelers, 1989-1992.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-01-15       Impact factor: 17.586

7.  Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.

Authors:  Jordi Cámara; Judit Serra; Josefina Ayats; Teresa Bastida; Dolors Carnicer-Pont; Antònia Andreu; Carmen Ardanuy
Journal:  J Antimicrob Chemother       Date:  2012-05-07       Impact factor: 5.790

8.  Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity.

Authors:  Sanjay Ram; Andrew D Cox; J Claire Wright; Ulrich Vogel; Silke Getzlaff; Ryan Boden; Jianjun Li; Joyce S Plested; Seppo Meri; Sunita Gulati; Daniel C Stein; James C Richards; E Richard Moxon; Peter A Rice
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

9.  Gonococcal invasion of epithelial cells driven by P.IA, a bacterial ion channel with GTP binding properties.

Authors:  J P van Putten; T D Duensing; J Carlson
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.

Authors:  S Ram; A K Sharma; S D Simpson; S Gulati; D P McQuillen; M K Pangburn; P A Rice
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

View more
  24 in total

1.  Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.

Authors:  Massimiliano Biagini; Marco Spinsanti; Gabriella De Angelis; Sara Tomei; Ilaria Ferlenghi; Maria Scarselli; Fabio Rigat; Nicola Messuti; Alessia Biolchi; Alessandro Muzzi; Giulia Anderloni; Brunella Brunelli; Elena Cartocci; Francesca Buricchi; Chiara Tani; Maria Stella; Monica Moschioni; Elena Del Tordello; Annalisa Colaprico; Silvana Savino; Marzia M Giuliani; Isabel Delany; Mariagrazia Pizza; Paolo Costantino; Nathalie Norais; Rino Rappuoli; Vega Masignani
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-17       Impact factor: 11.205

2.  Phosphoethanolamine decoration of Neisseria gonorrhoeae lipid A plays a dual immunostimulatory and protective role during experimental genital tract infection.

Authors:  Mathanraj Packiam; Roshan D Yedery; Afrin A Begum; Russell W Carlson; Jhuma Ganguly; Gregory D Sempowski; Melissa S Ventevogel; William M Shafer; Ann E Jerse
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 3.  Bacterial strategies of resistance to antimicrobial peptides.

Authors:  Hwang-Soo Joo; Chih-Iung Fu; Michael Otto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

4.  Analysis of Bacterial Lipooligosaccharides by MALDI-TOF MS with Traveling Wave Ion Mobility.

Authors:  Nancy J Phillips; Constance M John; Gary A Jarvis
Journal:  J Am Soc Mass Spectrom       Date:  2016-04-07       Impact factor: 3.109

5.  New Features in the Lipid A Structure of Brucella suis and Brucella abortus Lipopolysaccharide.

Authors:  Adriana C Casabuono; Cecilia Czibener; Mariela G Del Giudice; Ezequiel Valguarnera; Juan E Ugalde; Alicia S Couto
Journal:  J Am Soc Mass Spectrom       Date:  2017-09-18       Impact factor: 3.109

6.  Lipid a is more than acyl chains.

Authors:  Michael A Apicella
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

7.  Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

Authors:  Constance M John; Nancy J Phillips; Richard Din; Mingfeng Liu; Einar Rosenqvist; E Arne Høiby; Daniel C Stein; Gary A Jarvis
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

8.  Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.

Authors:  Srinjoy Chakraborti; Lisa A Lewis; Andrew D Cox; Frank St Michael; Jianjun Li; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2016-05-02       Impact factor: 5.422

9.  Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.

Authors:  Mark R Pelletier; Leila G Casella; Jace W Jones; Mark D Adams; Daniel V Zurawski; Karsten R O Hazlett; Yohei Doi; Robert K Ernst
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

10.  Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins.

Authors:  Sunita Gulati; Ian C Schoenhofen; Theresa Lindhout-Djukic; Lisa A Lewis; Iesha Y Moustafa; Sudeshna Saha; Bo Zheng; Nancy Nowak; Peter A Rice; Ajit Varki; Sanjay Ram
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.